- Price source
- Injection card; shared $144 headline refers to nasal spray
- Supply
- One month advertised
- Vial
- Concentration and volume require confirmation
Use the injection card for the injection price
Shed's NAD+ injection card lists a starting price of $169 per month and a one-month supply. The same page has a lower $144 heading because it also includes a nasal product at that price. This review uses the injection-specific figure rather than allowing the cheapest route to stand in for every product on the page.
The stated supply period is helpful, but the public card does not establish a universal vial specification. Ask for the actual concentration, volume, total amount and pharmacy associated with the prescription. A one-month package can describe a purchasing period without giving a reader enough information to determine an administration schedule independently.
Identify what is included in the monthly offer
Shed describes online intake, clinician review, pharmacy fulfillment and continuing access through its portal. Confirm which of those services are included in the selected price and whether supplies, delivery or any required testing create another charge. We have not completed checkout or obtained an individualized invoice showing the complete cost of care.
Also ask whether the monthly plan renews automatically, when another payment occurs and how the next pharmacy order is stopped. A starting monthly figure does not establish a fixed price for every future prescription. Retain the actual purchase terms rather than importing a cancellation or guarantee statement from a different treatment category elsewhere on the site.
Pharmacy and delivery details are route-specific
The injection requires its own dispensing and storage information. Request the pharmacy label and beyond-use instructions for the preparation actually supplied, including any conditions that change after the container is opened. The nasal bottle's handling requirements or an oral tablet's convenience claims cannot substitute for that information.
The provider advertises delivery to the patient after clinical approval. That describes a process rather than a guaranteed time from initial payment to receipt. Clarify who handles a damaged shipment, a temperature concern or a medical question after delivery, and distinguish customer-service availability from the response expected from the treating clinician.
What the wellness explanation can establish
Shed presents NAD+ in connection with cellular energy and healthy-aging goals. The role of the coenzyme in normal biology does not prove a specific benefit from this finished injection. We did not independently verify the advertised clinical effects, inspect a batch report or compare the product with the provider's other NAD+ routes in a controlled study.
The site identifies compounded products as not FDA-approved. The clinician should explain the intended purpose and relevant evidence, including uncertainty, before treatment is considered. This review's practical finding is a clearly separated $169 injection starting price with a one-month supply description. Its usefulness depends on keeping those commercial facts distinct from the unresolved prescription details and any expectation of a health outcome.
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.